Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Alarcón GS[au]:

Epidemiology of systemic lupus erythematosus. Pons-Estel GJ et al. Expert Rev Clin Immunol. (2017)

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Petri M et al. Arthritis Rheum. (2012)

Transancestral mapping and genetic load in systemic lupus erythematosus. Langefeld CD et al. Nat Commun. (2017)

Search results

Items: 1 to 50 of 559

1.

Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective.

Pons-Estel GJ, Ugarte-Gil MF, Harvey GB, Wojdyla D, Quintana R, Saurit V, Soriano ER, Bonfa E, Massardo L, Cardiel M, Vila LM, Griffin R, Pons-Estel BA, Alarcón GS; Grupo Latino Americano De Estudio de Lupus (GLADEL).

RMD Open. 2020 Jan;6(1). pii: e001097. doi: 10.1136/rmdopen-2019-001097.

PMID:
31958284
2.

Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.

Hanly JG, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Farewell V.

Ann Rheum Dis. 2020 Jan 8. pii: annrheumdis-2019-216150. doi: 10.1136/annrheumdis-2019-216150. [Epub ahead of print]

PMID:
31915121
3.

Reliability of Visual Analog Scale and Numeric Rating Scale for the Assessment of Disease Activity in Systemic Lupus Erythematosus.

Elera-Fitzcarrald C, Vega K, Gamboa-Cárdenas RV, Zúñiga K, Zevallos F, Reátegui-Sokolova C, Pastor-Asurza C, Perich-Campos R, Rodríguez Bellido Z, Aranow C, Alarcón GS, Calvo A, Ugarte-Gil MF.

J Clin Rheumatol. 2019 Dec 31. doi: 10.1097/RHU.0000000000001274. [Epub ahead of print]

PMID:
31899713
4.

Discrepant Perception of Lupus Disease Activity: A Comparison Between Patients' and Physicians' Disease Activity Scores.

Elera-Fitzcarrald C, Vega K, Gamboa-Cárdenas RV, Zúñiga K, Medina M, Pimentel-Quiroz V, Pastor-Asurza C, Perich-Campos R, Rodríguez Bellido Z, Griffin R, Aranow C, Alarcón GS, Calvo A, Ugarte-Gil MF.

J Clin Rheumatol. 2019 Dec 31. doi: 10.1097/RHU.0000000000001267. [Epub ahead of print]

PMID:
31895090
5.

A Critical Analysis of the First Latin American Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus.

Alarcón GS, Cardiel MH, Izcovich A, Scheinberg M, Pons-Estel BA.

J Clin Rheumatol. 2019 Dec 31. doi: 10.1097/RHU.0000000000001265. [Epub ahead of print] No abstract available.

PMID:
31895089
6.

Prediction of damage accrual in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin PR, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Oct 21. doi: 10.1002/art.41144. [Epub ahead of print]

PMID:
31631584
7.

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.

Enocsson H, Wirestam L, Dahle C, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma AA, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, van Vollenhoven RF, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken CA, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Autoimmun. 2020 Jan;106:102340. doi: 10.1016/j.jaut.2019.102340. Epub 2019 Oct 17.

8.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
9.

Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.

Reátegui-Sokolova C, Rodríguez-Bellido Z, Gamboa-Cárdenas RV, Medina M, Zevallos F, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Cucho-Venegas M, Pastor-Asurza CA, Perich-Campos R, Alarcón GS, Ugarte-Gil MF.

Lupus. 2019 Oct;28(11):1344-1349. doi: 10.1177/0961203319876998. Epub 2019 Sep 24.

PMID:
31551028
10.

Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Massardo L, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2963-2964. doi: 10.1007/s10067-019-04742-8.

PMID:
31432337
11.

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Svenungsson E, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2020 Jan;72(1):67-77. doi: 10.1002/art.41070. Epub 2019 Nov 28.

PMID:
31390162
12.

Lupus: the new epidemic.

Ugarte-Gil MF, González LA, Alarcón GS.

Lupus. 2019 Aug;28(9):1031-1050. doi: 10.1177/0961203319860907. Epub 2019 Jul 12. Review.

PMID:
31299878
13.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2019 Aug;28(9):1101-1110. doi: 10.1177/0961203319860579. Epub 2019 Jul 10.

PMID:
31291843
14.

Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.

Ugarte-Gil MF, Pons-Estel GJ, Vila LM, McGwin G, Alarcón GS.

RMD Open. 2019 May 23;5(1):e000955. doi: 10.1136/rmdopen-2019-000955. eCollection 2019.

15.

Low Disease Activity State/Remission Predicts a Better Health-Related Quality of Life in Systemic Lupus Erythematosus Patients.

Ugarte-Gil MF, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Medina-Chinchón M, Zevallos F, Elera-Fitzcarrald C, Pimentel-Quiroz V, Cucho-Venegas JM, Rodríguez-Bellido Z, Pastor-Asurza CA, Alarcón GS, Perich-Campos R.

Arthritis Care Res (Hoboken). 2019 Jun 14. doi: 10.1002/acr.24009. [Epub ahead of print]

PMID:
31199590
16.

Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Loreto M, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2737-2746. doi: 10.1007/s10067-019-04618-x. Epub 2019 Jun 3. Erratum in: Clin Rheumatol. 2019 Aug 20;:.

PMID:
31161486
17.

Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al.

Gómez-Puerta JA, Cervera R, Alarcón GS.

Arthritis Rheumatol. 2019 Oct;71(10):1768-1769. doi: 10.1002/art.41002. Epub 2019 Sep 2. No abstract available.

PMID:
31131989
18.

Medical Scientific Publications From Latin America: A Commentary.

Ugarte-Gil MF, Alarcón GS.

J Clin Rheumatol. 2019 Jun;25(4):157-158. doi: 10.1097/RHU.0000000000000907. No abstract available.

PMID:
31125322
19.

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.

Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL Jr, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J.

PLoS Med. 2019 May 8;16(5):e1002800. doi: 10.1371/journal.pmed.1002800. eCollection 2019 May.

20.

Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Zeña-Huancas PA, Iparraguirre-López H, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Zevallos-Miranda F, Medina-Chinchon M, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Sarmiento-Velasquez O, Cucho-Venegas JM, Alfaro-Lozano JL, Rodríguez-Bellido ZJ, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.

Clin Rheumatol. 2019 Jun;38(6):1799. doi: 10.1007/s10067-019-04558-6.

PMID:
31037457
21.

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

J Rheumatol. 2020 Jan;47(1):72-81. doi: 10.3899/jrheum.181338. Epub 2019 Apr 15.

PMID:
30988130
22.

Erratum corrige: "Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients". M.F. Ugarte-Gil et al.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cardenas RV, Aliaga-Zamudio M, Zevallos F, Mosqueira-Riveros A, Medina-Chinchón M, Tineo-Pozo G, Elera-Fitzcarrald C, Pimentel-Quiroz V, Sarmiento-Velasquez O, Reátegui-Sokolova C, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza CA, Alarcón GS, Perich-Campos R.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):345. Epub 2019 Mar 19. No abstract available.

23.

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Quintana R, Gómez-Puerta JA, Catoggio LJ, Alvarellos A, Saurit V, Borba E, Sato E, Costallat L, Da Silva NA, Iglesias-Gamarra A, Neira O, Reyes-Llerena G, Cardiel MH, Amigo MC, Acevedo-Vásquez E, Esteva-Spinetti MH, Alarcón GS, Pons-Estel BA.

J Rheumatol. 2019 Oct;46(10):1299-1308. doi: 10.3899/jrheum.180433. Epub 2019 Mar 1.

PMID:
30824636
24.

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus.

Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG.

Arthritis Rheumatol. 2019 Aug;71(8):1297-1307. doi: 10.1002/art.40859. Epub 2019 May 29.

PMID:
30771242
25.

Fatigue Measurements in Systemic Lupus Erythematosus.

Barbacki A, Petri M, Aviña-Zubieta A, Alarcón GS, Bernatsky S.

J Rheumatol. 2019 Nov;46(11):1470-1477. doi: 10.3899/jrheum.180831. Epub 2019 Feb 1.

PMID:
30709953
26.

Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.

Alarcón GS, Ugarte-Gil MF, Pons-Estel G, Vilá LM, Reveille JD, McGwin G Jr.

Lupus. 2019 Mar;28(3):423-426. doi: 10.1177/0961203319826693. Epub 2019 Jan 24.

PMID:
30678605
27.

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.

J Rheumatol. 2019 May;46(5):492-500. doi: 10.3899/jrheum.180713. Epub 2019 Jan 15.

28.

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.

Mendel A, Bernatsky SB, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Wallace DJ, Merrill JT, Buyon JP, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin PR, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN, Costedoat-Chalumeau N, Vinet É.

Ann Rheum Dis. 2019 Jul;78(7):1010-1012. doi: 10.1136/annrheumdis-2018-214434. Epub 2018 Dec 20. No abstract available.

29.

Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.

Zeña-Huancas PA, Iparraguirre-López H, Gamboa-Cárdenas RV, Reátegui-Sokolova C, Zevallos-Miranda F, Medina-Chinchon M, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Sarmiento-Velasquez O, Cucho-Venegas JM, Alfaro-Lozano JL, Rodríguez-Bellido ZJ, Pastor-Asurza CA, Perich-Campos RA, Alarcón GS, Ugarte-Gil MF.

Clin Rheumatol. 2019 Apr;38(4):1139-1146. doi: 10.1007/s10067-018-4389-3. Epub 2018 Dec 12. Erratum in: Clin Rheumatol. 2019 Apr 29;:.

PMID:
30539353
30.

A Practical Roadmap for Writing of Medical Scientific Publications.

Ugarte-Gil MF, Alarcón GS.

J Clin Rheumatol. 2019 Oct;25(7):314-317. doi: 10.1097/RHU.0000000000000944.

PMID:
30520825
31.

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2019 Feb;71(2):281-289. doi: 10.1002/art.40764. Epub 2019 Jan 18.

32.

Response to: 'Clinical evidence guidelines in systemic lupus erythematosus: revaluation' by Scheinberg.

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Vázquez G, Alarcón GS.

Ann Rheum Dis. 2019 Nov;78(11):e120. doi: 10.1136/annrheumdis-2018-214385. Epub 2018 Oct 23. No abstract available.

PMID:
30352890
33.

Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions.

Elera-Fitzcarrald C, Fuentes A, González LA, Burgos PI, Alarcón GS, Ugarte-Gil MF.

Expert Rev Clin Immunol. 2018 Nov;14(11):915-931. doi: 10.1080/1744666X.2018.1529566. Epub 2018 Oct 8. Review.

PMID:
30266076
34.

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS.

Arthritis Rheumatol. 2018 Dec;70(12):2098-2099. doi: 10.1002/art.40694. Epub 2018 Sep 24. No abstract available.

35.

Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans.

Hanscombe KB, Morris DL, Noble JA, Dilthey AT, Tombleson P, Kaufman KM, Comeau M, Langefeld CD, Alarcon-Riquelme ME, Gaffney PM, Jacob CO, Sivils KL, Tsao BP, Alarcon GS, Brown EE, Croker J, Edberg J, Gilkeson G, James JA, Kamen DL, Kelly JA, McCune J, Merrill JT, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Scofield H, Utset T, Wallace DJ, Weisman MH, Kimberly RP, Harley JB, Lewis CM, Criswell LA, Vyse TJ.

Hum Mol Genet. 2018 Nov 1;27(21):3813-3824. doi: 10.1093/hmg/ddy280.

36.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

37.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712. Epub 2019 Jun 12.

PMID:
30044551
38.

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.

Patel ZH, Lu X, Miller D, Forney CR, Lee J, Lynch A, Schroeder C, Parks L, Magnusen AF, Chen X, Pujato M, Maddox A, Zoller EE, Namjou B, Brunner HI, Henrickson M, Huggins JL, Williams AH, Ziegler JT, Comeau ME, Marion MC, Glenn SB, Adler A, Shen N, Nath SK, Stevens AM, Freedman BI, Pons-Estel BA, Tsao BP, Jacob CO, Kamen DL, Brown EE, Gilkeson GS, Alarcón GS, Martin J, Reveille JD, Anaya JM, James JA, Sivils KL, Criswell LA, Vilá LM, Petri M, Scofield RH, Kimberly RP, Edberg JC, Ramsey-Goldman R, Bang SY, Lee HS, Bae SC, Boackle SA, Cunninghame Graham D, Vyse TJ, Merrill JT, Niewold TB, Ainsworth HC, Silverman ED, Weisman MH, Wallace DJ, Raj P, Guthridge JM, Gaffney PM, Kelly JA, Alarcón-Riquelme ME, Langefeld CD, Wakeland EK, Kaufman KM, Weirauch MT, Harley JB, Kottyan LC.

Hum Mol Genet. 2018 Jul 1;27(13):2392-2404. doi: 10.1093/hmg/ddy140.

39.

A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients.

Pons-Estel GJ, Quintana R, Alarcón GS, Sacnún M, Ugarte-Gil MF, Pons-Estel BA; GLADEL.

Lupus. 2018 Sep;27(10):1753-1754. doi: 10.1177/0961203318776104. Epub 2018 May 15. No abstract available.

PMID:
29764291
40.

Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients.

Ugarte-Gil MF, Sánchez-Zúñiga C, Gamboa-Cardenas RV, Aliaga-Zamudio M, Zevallos F, Mosqueira-Riveros A, Medina-Chinchón M, Tineo-Pozo G, Elera-Fitzcarrald C, Pimentel-Quiroz V, Sarmiento-Velasquez O, Reátegui-Sokolova C, Cucho-Venegas JM, Alfaro-Lozano J, Rodriguez-Bellido Z, Pastor-Asurza C, Alarcón GS, Perich-Campos R.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1008-1013. Epub 2018 May 8. Erratum in: Clin Exp Rheumatol. 2019 Mar-Apr;37(2):345.

PMID:
29745892
41.

Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study.

Quintana R, Goñi M, Mathern N, Jorfen M, Conti S, Nieto R, Sanabria A, Prigione C, Silvestre AMR, García V, Pons-Estel G, Cervera R, García C, Peláez-Ballestas I, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2018 Sep;37(9):2323-2330. doi: 10.1007/s10067-018-4103-5. Epub 2018 Apr 19.

PMID:
29675622
42.

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN.

Rheumatology (Oxford). 2018 Apr 1;57(4):677-687. doi: 10.1093/rheumatology/kex444.

43.

Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1478-1487. doi: 10.1002/acr.23509. Epub 2018 Sep 1.

44.

Remission or low disease activity as a target in systemic lupus erythematosus.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Pons-Estel BA, Alarcón GS; GLADEL.

Ann Rheum Dis. 2019 Jan;78(1):e3. doi: 10.1136/annrheumdis-2017-212876. Epub 2018 Jan 8. No abstract available.

PMID:
29311147
45.

Therapeutic Guidelines for Latin American Lupus Patients: Methodology.

Cardiel MH, Soriano ER, Bonfá ESDO, Alarcón GS, Izcovich A, Amigo Castañeda MC, Barile-Fabris LA, Duarte M, Espada G, García MA, Levy RA, Massardo L, Sato EI, Vásquez G, Acevedo-Vásquez EM, Catoggio LJ, Chacón-Díaz R, Galarza Maldonado CM, Iglesias Gamarra AJ, Molina Restrepo JF, Neira O, Silva CA, Vargas Peña A, Pons-Estel BA.

J Clin Rheumatol. 2018 Jan;24(1):41-44. doi: 10.1097/RHU.0000000000000662. No abstract available.

PMID:
29200029
46.

Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1294-1302. doi: 10.1002/acr.23480. Epub 2018 Aug 17.

47.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
48.

Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.

Ugarte-Gil MF, Wojdyla D, Pastor-Asurza CA, Gamboa-Cárdenas RV, Acevedo-Vásquez EM, Catoggio LJ, García MA, Bonfá E, Sato EI, Massardo L, Pascual-Ramos V, Barile LA, Reyes-Llerena G, Iglesias-Gamarra A, Molina-Restrepo JF, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2018 Apr;27(4):536-544. doi: 10.1177/0961203317728810. Epub 2017 Aug 31.

PMID:
28857715
49.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

50.

Defining Quality of Rheumatologic Care: Peru.

Reátegui-Sokolova C, Pimentel-Quiroz VR, Elera-Fitzcarrald C, Ugarte-Gil MF, Calvo A, Alarcón GS.

J Clin Rheumatol. 2017 Jun;23(4):212-214. doi: 10.1097/RHU.0000000000000527. No abstract available.

PMID:
28538276

Supplemental Content

Loading ...
Support Center